Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Trends in Endocrinology and Metabolism: TEM
|
April 26, 2003
Insulin-like growth factor binding protein proteolysis
R Clay Bunn, John L Fowlkes
Bone
|
June 18, 2021
RASopathies: The musculoskeletal consequences and their etiology and pathogenesis
John L Fowlkes, Kathryn M Thrailkill, R Clay Bunn
Endocrine
|
October 31, 2008
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy
Kathryn M Thrailkill, R Clay Bunn, John L Fowlkes
Pediatric Research
|
March 19, 2005
Early developmental changes in IGF-I, IGF-II, IGF binding protein-1, and IGF binding protein-3 concentration in the cerebrospinal fluid of children
R Clay Bunn, William D King, Margaret K Winkler, et al.
Current Osteoporosis Reports
|
October 6, 2016
Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts
Evangelia Kalaitzoglou, Iuliana Popescu, R Clay Bunn, et al.
Bone
|
February 14, 2018
Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age
Amy Creecy, Sasidhar Uppuganti, Mustafa Unal, et al.
Biochemical and Biophysical Research Communications
|
November 16, 2004
IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts
R Clay Bunn, Latonya D Green, Michael T Overgaard, et al.
Scientific Reports
|
June 3, 2020
Postnatal loss of the insulin receptor in osteoprogenitor cells does not impart a metabolic phenotype
John L Fowlkes, R Clay Bunn, Evangelia Kalaitzoglou, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 11, 2005
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Kathryn M Thrailkill, Charles K Lumpkin, R Clay Bunn, et al.
Bone Reports
|
July 25, 2017
Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes
Jeffry S Nyman, Evangelia Kalaitzoglou, R Clay Bunn, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Trends in Endocrinology and Metabolism: TEM
|
April 26, 2003
Insulin-like growth factor binding protein proteolysis
R Clay Bunn, John L Fowlkes
Bone
|
June 18, 2021
RASopathies: The musculoskeletal consequences and their etiology and pathogenesis
John L Fowlkes, Kathryn M Thrailkill, R Clay Bunn
Endocrine
|
October 31, 2008
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy
Kathryn M Thrailkill, R Clay Bunn, John L Fowlkes
Pediatric Research
|
March 19, 2005
Early developmental changes in IGF-I, IGF-II, IGF binding protein-1, and IGF binding protein-3 concentration in the cerebrospinal fluid of children
R Clay Bunn, William D King, Margaret K Winkler, et al.
Current Osteoporosis Reports
|
October 6, 2016
Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts
Evangelia Kalaitzoglou, Iuliana Popescu, R Clay Bunn, et al.
Bone
|
February 14, 2018
Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age
Amy Creecy, Sasidhar Uppuganti, Mustafa Unal, et al.
Biochemical and Biophysical Research Communications
|
November 16, 2004
IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts
R Clay Bunn, Latonya D Green, Michael T Overgaard, et al.
Scientific Reports
|
June 3, 2020
Postnatal loss of the insulin receptor in osteoprogenitor cells does not impart a metabolic phenotype
John L Fowlkes, R Clay Bunn, Evangelia Kalaitzoglou, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 11, 2005
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Kathryn M Thrailkill, Charles K Lumpkin, R Clay Bunn, et al.
Bone Reports
|
July 25, 2017
Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes
Jeffry S Nyman, Evangelia Kalaitzoglou, R Clay Bunn, et al.
Page
of 3